arrow
J

Joseph H. Antin

Harvard University
H指数:118
被引数:4.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Venetoclax-augmented RIC allogeneic HCT with PTCy-based GVHD prophylaxis and venetoclax/azacitidine maintenance for poor risk MDS and AML

维奈克拉增强的RIC同种异基因HCT联合PTCy为基础的GVHD预防及维奈克拉/阿扎胞苷维持治疗高危MDS和AML

2026-08-190
OAAI
Expression of HLA-B*35 is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-based Hematopoietic Cell Transplantation

HLA-B*35的表达与PTCy-based造血细胞移植后巨细胞病毒(CMV)病毒血症及临床显著CMV感染风险的增加相关。

2025-09-210
PRE
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant CyclophosphamideBased Graft-Versus-Host Disease Prophylaxis

供体类型不影响低强度异基因造血细胞移植后的晚期移植失败,移植后基于环磷酰胺的移植物抗宿主病预防

2025-03-010
PRE
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy

异基因造血干细胞移植治疗重型再生障碍性贫血: 美国移植与细胞治疗学会循证指南

2024-12-011
OAAI
Expression of HLA-B*35 Is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

HLA-B*35的表达与接受Ptcy为基础造血细胞移植的患者发生巨细胞病毒(CMV)病毒血症和临床显著CMV感染风险增加相关。

BLOOD
IF23.1
2024-11-050
PRE
Early CMV Viral Load Burden Predicts Late Clinically Significant CMV Infections in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

早期巨细胞病毒(CMV)病毒载量负担可预测接受Ptcy为基础的造血细胞移植患者晚期临床显著CMV感染。

BLOOD
IF23.1
2024-11-050
PRE
A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH) A Pilot Randomized Clinical Trial

异基因造血干细胞移植幸存者 (PATH) 的积极心理干预

2024-06-013
OA
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML
2024-02-165
OAAI
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

低强度预处理异基因造血干细胞移植后早期急性肾损伤的临床特征

2023-07-014
OAAI